On April 14 and 15, 2025, Professor Marion Leboyer was in Munich to set up a Franco-German collaboration on research and innovation in psychiatry.
Mental disorders are one of the main causes of disability, placing considerable pressure on healthcare systems, the economy and society.
Despite advances in neuroscience, psychiatry lacks effective, personalized treatments, largely due to the biological and clinical heterogeneity of mental disorders.
Traditional symptom-based approaches have proved insufficient, and the development of psychiatric drugs has stagnated.
In this context, it is important to exploit artificial intelligence tools to process existing multimodal data and identify homogeneous subgroups that can benefit from specialized treatments.
The major themes addressed were:
- Precision psychiatry,
- Biomarker discovery,
- Artificial intelligence.
These meetings mark a key stage in the strengthening of scientific cooperation and the pooling of expertise, as we work together to meet European challenges in mental health.